Found 29 clinical trials
-
Accepting pediatric ages
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Long-term Antipsychotic Pediatric Safety Trial
The purpose is to evaluate the long-term pathologic weight changes associated with multi-year risperidone or aripiprazole therapy in 3 - <18-year-old children, who have varying durations of
- 64 views
- 24 Feb, 2021
- 39 locations
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
include quetiapine, olanzapine, risperidone, aripiprazole, ziprasidone, paliperidone , amisulpride , perospirone and clozapine. This is an open, cohort, multi-center observational clinical study. The main
- 0 views
- 23 Jan, 2021
- 1 location
-
1000s of participants
-
An observational study
-
For all genders
-
Family Medicine
-
Currently Recruiting
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
(olanzapine, risperidone, aripiprazole, ziprasidone, amisulpride, haloperidol). Through 8-week treatment and follow-up, we collect multidimensional indexes from psychopathology, neuropsychology, brain imaging
- 5 views
- 30 Jan, 2021
- 1 location
-
Accepting adults
-
1000s of participants
-
An observational study
-
For females only
-
Family Medicine
-
Currently Recruiting
National Pregnancy Registry for Atypical Antipsychotics
The purpose of the National Pregnancy Registry for Atypical Antipsychotics is to determine the frequency of birth defects among infants exposed to atypical antipsychotics.
- 352 views
- 24 Jan, 2021
- 1 location
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Family Medicine
-
Currently Recruiting
Effect on Metabolic Parameters of Abilify in SPR
To measure the long-term changes in weight and plasma lipids after switching antipsychotic treatment to aripiprazole
- 6 views
- 07 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Psychiatry/Psychology
-
Currently Recruiting
Striatal Connectivity and Clinical Outcome in Psychosis
risperidone or aripiprazole. Patients who present for treatment of a first psychotic episode with a schizophrenia spectrum diagnosis and who are eligible to undergo treatment with either risperidone or
- 64 views
- 26 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
The aim of this study is observation, in an Italian real-world setting, of metabolic effects in patients with schizophrenia who will switch from any mono-therapy or poly-therapy antipsychotic regimen to monotherapy with lurasidone or to one of the other four most used atypical antipsychotics.
- 0 views
- 25 Jan, 2021
- 15 locations
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Family Medicine
-
Currently Recruiting
Side Effects of Antipsychotic Medications
Medications like olanzapine have been associated with the development of weight gain and diabetes in some patients. It is not known if the increased risk of developing diabetes is a direct effect on insulin or simply related to weight gain. We hope to learn in this study whether or not …
- 132 views
- 07 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population
Introduction: Second Generation Antipsychotics (SGAs) are widely used in the pediatric population. It is currently established that SGAs may induce undesirable metabolic adverse events (AEs) such as weight gain, metabolic changes in blood lipids or glucose with risk of potential cardiovascular morbidity and mortality. The Canadian Alliance for Monitoring Effectiveness …
- 15 views
- 24 Jan, 2021
- 1 location